This price move could be a signal that ETNB may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options. A.I.dvisor backtested 41 similar cases where ETNB's price broke its higher Bollinger Band, and of them led to a successful outcome. Odds of Success:
a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases